Sugar Text: A Randomized Controlled Trial of a Text Message Intervention for Women With Diabetes in Pregnancy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-01-31

Study Completion Date

2014-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Maternal diabetes in pregnancy can negatively impact fetal well-being and contribute to adverse pregnancy outcomes. Much of the morbidity associated with diabetes in pregnancy can be minimized with tight glucose control. A number of studies in non-pregnant populations have highlighted the feasibility, acceptability and efficacy of text messaging interventions for improving diabetic compliance and control. This study will investigate whether a text messaging intervention is feasible and effective in an urban, diabetic, obstetric clinic and whether this intervention can improve compliance with diabetes care, glucose control and pregnancy outcomes. The study will also assess satisfaction with the intervention itself.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Texting for Diabetes

NCT03025984

Diabetes Mellitus

ACTIVE_NOT_RECRUITING NA

Texting for Diabetes Success in Pregnancy

NCT03240289

Gestational Diabetes Pregnancy in Diabetics

COMPLETED NA

Text Message for Adolescents With Poorly Controlled Type 1 Diabetes

NCT02230137

Type 1 Diabetes

COMPLETED NA

SweetMama: Testing of a Novel Technology for Diabetes Education and Support to Pregnant Women

NCT03240874

Diabetes Mellitus in Pregnancy

COMPLETED NA

Text-message Reminders to Increase Rates of Postpartum Diabetes Screening in Women With Gestational Diabetes

NCT02013557

Diabetes, Gestational

TERMINATED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes in Pregnancy Gestational Diabetes Texting Interventions

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Routine Care

Group Type NO_INTERVENTION

No interventions assigned to this group

Text Message Intervention

The text message intervention group receives usual prenatal and diabetic care in addition to two text messages per week throughout the pregnancy and a reminder text message prior to the postpartum visit. The text message intervention group also fills out a survey about the intervention after delivery.

Group Type EXPERIMENTAL

Text Message Intervention

Intervention Type BEHAVIORAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Text Message Intervention

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pregnant women aged 18-50 years
* Planned delivery at Hospital of the University of Pennsylvania

Exclusion Criteria

* Gestational age greater than 34 weeks at initial visit in the Penn Perinatal Diabetes Program
* Women who are unable to read English as all text messages will be in English
* Women who do not have a cellular phone capable of receiving text messages as this is the study intervention

Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Celeste Durnwald

Assistant Professor, Maternal Fetal Medicine, Department of Obstetrics and Gynecology Director, Penn Perinatal Diabetes Program Director, High Risk Clinic at the Helen O. Dickens Center for Women's Health

Responsibility Role PRINCIPAL_INVESTIGATOR